• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不明来源栓塞性卒中和其他卒中亚型患者的复发卒中发生率和病因。

Recurrent Stroke Incidence and Etiology in Patients with Embolic Stroke of Undetermined Source and Other Stroke Subtypes.

机构信息

Department of Neurology, Tokyo Women's Medical University.

出版信息

J Atheroscler Thromb. 2022 Mar 1;29(3):393-402. doi: 10.5551/jat.61895. Epub 2021 Feb 18.

DOI:10.5551/jat.61895
PMID:33597329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8894114/
Abstract

AIMS

This study aimed at clarifying the incidence of recurrent stroke and its etiology in patients with embolic stroke of undetermined source (ESUS) and other stroke subtypes in both the acute and chronic periods.

METHODS

A total of 645 patients who were admitted with acute ischemic stroke (IS) between March 2015 and August 2019 were enrolled. Among them, 511 patients with ESUS, cardioembolism (CE), large artery atherosclerosis (LAA), or small vessel disease (SVD) were analyzed in this study. After discharge, 391 patients who visited the outpatient clinic were followed up until August 2020. The outcome was stroke recurrence.

RESULTS

In the acute admission, recurrence rates were 7.6%, 8.1%, 18.8%, and 2.2% in patients with ESUS, CE, LAA, and SVD, respectively, and there were significant differences between the groups. The subtype of recurrence was almost identical to that of the index stroke. In the outpatient clinic, the annual recurrence rates were 4.4%, 4.3%, 6.0%, and 2.9% in ESUS, CE, LAA, and SVD, respectively, and no difference was observed. Subtypes of recurrence in outpatients with ESUS included ESUS, intracerebral hemorrhage (ICH), and SVD. Patients with ESUS and SVD had a higher risk of ICH during follow-up.

CONCLUSIONS

Although the risk of recurrence was comparable between patients with ESUS and CE and intermediate between patients with LAA and SVD, in the acute admission unit, the risk in outpatients was similar among all subtypes. ESUS was the most recurrent stroke subtype in outpatients with ESUS. The risk of hemorrhagic stroke was significant in patients with SVD and ESUS.

摘要

目的

本研究旨在阐明不明来源栓塞性卒中(ESUS)和其他卒中亚型患者在急性期和慢性期内复发性卒中的发生率及其病因。

方法

共纳入 2015 年 3 月至 2019 年 8 月期间因急性缺血性卒中(IS)入院的 645 例患者。其中,511 例 ESUS、心源性栓塞(CE)、大动脉粥样硬化(LAA)或小血管疾病(SVD)患者纳入本研究。出院后,391 例门诊就诊患者随访至 2020 年 8 月。结局为卒中复发。

结果

在急性期,ESUS、CE、LAA 和 SVD 患者的复发率分别为 7.6%、8.1%、18.8%和 2.2%,组间差异有统计学意义。复发性卒中亚型与指数性卒中几乎一致。在门诊期间,ESUS、CE、LAA 和 SVD 患者的年复发率分别为 4.4%、4.3%、6.0%和 2.9%,差异无统计学意义。ESUS 门诊患者的复发性卒中亚型包括 ESUS、脑出血(ICH)和 SVD。ESUS 和 SVD 患者在随访期间ICH 风险较高。

结论

尽管 ESUS 患者与 CE 患者的复发风险相当,且介于 LAA 患者与 SVD 患者之间,但在急性期住院患者中,所有亚型的门诊患者的复发风险相似。在 ESUS 门诊患者中,ESUS 是最常见的复发性卒中亚型。SVD 和 ESUS 患者的出血性卒中风险显著。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/8894114/a879e709b4e2/29_61895_3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/8894114/0c8c5aded714/29_61895_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/8894114/1e9cd56be3f4/29_61895_2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/8894114/a879e709b4e2/29_61895_3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/8894114/0c8c5aded714/29_61895_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/8894114/1e9cd56be3f4/29_61895_2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/8894114/a879e709b4e2/29_61895_3.jpg

相似文献

1
Recurrent Stroke Incidence and Etiology in Patients with Embolic Stroke of Undetermined Source and Other Stroke Subtypes.不明来源栓塞性卒中和其他卒中亚型患者的复发卒中发生率和病因。
J Atheroscler Thromb. 2022 Mar 1;29(3):393-402. doi: 10.5551/jat.61895. Epub 2021 Feb 18.
2
Atrial cardiopathy in embolic stroke of undetermined source.不明来源栓塞性卒中的心房心肌病
Brain Behav. 2021 Jun;11(6):e02160. doi: 10.1002/brb3.2160. Epub 2021 May 4.
3
Atrial cardiopathy in patients with embolic strokes of unknown source and other stroke etiologies.不明来源栓塞性脑卒中及其他脑卒中病因患者的心房心肌病。
Neurology. 2019 Jan 22;92(4):e288-e294. doi: 10.1212/WNL.0000000000006748. Epub 2018 Dec 5.
4
Reclassification and risk stratification of embolic stroke of undetermined source by ASCOD phenotyping.采用 ASCOD 表型学分型不明来源栓塞性脑卒中的再分类和危险分层。
Int J Stroke. 2023 Mar;18(3):322-330. doi: 10.1177/17474930221096953. Epub 2022 May 11.
5
Impaired Endothelial Function in Embolic Stroke of Undetermined Source.不明来源栓塞性卒中患者的血管内皮功能受损。
J Stroke Cerebrovasc Dis. 2020 Jan;29(1):104489. doi: 10.1016/j.jstrokecerebrovasdis.2019.104489. Epub 2019 Nov 6.
6
Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.不明来源栓塞性卒中后复发缺血性卒中的特征:一项随机临床试验的二次分析。
JAMA Neurol. 2020 Oct 1;77(10):1233-1240. doi: 10.1001/jamaneurol.2020.1995.
7
The ASCOD Phenotyping of Embolic Strokes of Undetermined Source.不明来源栓塞性卒中的 ASCOD 表型。
J Stroke Cerebrovasc Dis. 2020 Feb;29(2):104491. doi: 10.1016/j.jstrokecerebrovasdis.2019.104491. Epub 2019 Nov 21.
8
Prevalence and Prognostic Value of Atrial Cardiopathy in Embolic Stroke of Undetermined Source.不明来源栓塞性脑卒中中心房心肌病的患病率和预后价值。
Cerebrovasc Dis. 2024;53(5):556-563. doi: 10.1159/000535301. Epub 2023 Nov 19.
9
Prevalence of Microembolic Signals in Embolic Stroke of Undetermined Source and Other Subtypes of Ischemic Stroke.不明来源栓塞性卒中和其他缺血性卒中类型中的微栓子信号的发生率。
Stroke. 2020 Feb;51(2):655-658. doi: 10.1161/STROKEAHA.119.027008. Epub 2019 Nov 27.
10
Magnetic Resonance Imaging White Matter Hyperintensity as a Predictor of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source.磁共振成像白质高信号作为不明来源栓塞性卒中患者卒中复发的预测指标
J Stroke Cerebrovasc Dis. 2018 Dec;27(12):3613-3620. doi: 10.1016/j.jstrokecerebrovasdis.2018.08.033. Epub 2018 Sep 21.

引用本文的文献

1
The incidence of atrial fibrillation detected by implantable loop recorders: a comparison between patients with and without embolic stroke of undetermined source.植入式循环记录仪检测到的心房颤动发生率:不明来源栓塞性卒中患者与非此类患者的比较。
Eur Heart J Open. 2024 Sep 1;4(5):oeae061. doi: 10.1093/ehjopen/oeae061. eCollection 2024 Sep.
2
Incidence of recurrent ischemic stroke and its associated factors in a tertiary care center in Thailand: a retrospective cohort study.泰国一家三级护理中心复发性缺血性中风的发生率及其相关因素:一项回顾性队列研究。
BMC Neurol. 2024 May 4;24(1):152. doi: 10.1186/s12883-024-03640-0.
3

本文引用的文献

1
Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.不明来源栓塞性卒中后复发缺血性卒中的特征:一项随机临床试验的二次分析。
JAMA Neurol. 2020 Oct 1;77(10):1233-1240. doi: 10.1001/jamaneurol.2020.1995.
2
Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source: NAVIGATE-ESUS Trial.不明来源栓塞性卒中患者大出血的发生率及预测因素:NAVIGATE-ESUS 试验。
Stroke. 2020 Jul;51(7):2139-2147. doi: 10.1161/STROKEAHA.119.027995. Epub 2020 Jun 10.
3
Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke: A Randomized Clinical Trial and Meta-analysis.
Reminiscence therapy is a feasible care program for improving cognitive function, anxiety, and depression in recurrent acute ischemic stroke patients: a randomized, controlled study.
怀旧疗法是一种可行的护理方案,可改善复发性急性缺血性脑卒中患者的认知功能、焦虑和抑郁:一项随机对照研究。
Ir J Med Sci. 2023 Jun;192(3):1463-1471. doi: 10.1007/s11845-022-03114-7. Epub 2022 Jul 27.
4
The Relationship Between Aortic Arch Calcification and Recurrent Stroke in Patients With Embolic Stroke of Undetermined Source-A Case-Control Study.不明来源栓塞性卒中患者主动脉弓钙化与复发性卒中的关系——一项病例对照研究
Front Neurol. 2022 Apr 25;13:863450. doi: 10.3389/fneur.2022.863450. eCollection 2022.
5
Long-Term Trends in The 5-Year Risk of Recurrent Stroke over A Half Century in A Japanese Community: The Hisayama Study.半个世纪以来日本社区复发性卒中 5 年风险的长期趋势:久山研究。
J Atheroscler Thromb. 2022 Dec 1;29(12):1759-1773. doi: 10.5551/jat.63344. Epub 2022 Feb 19.
标准血压控制与强化血压控制对复发性中风风险的影响:一项随机临床试验和荟萃分析。
JAMA Neurol. 2019 Nov 1;76(11):1309-1318. doi: 10.1001/jamaneurol.2019.2167.
4
Branch atheromatous disease diagnosed as embolic stroke of undetermined source: A sub-analysis of NAVIGATE ESUS.分支动脉粥样硬化性疾病诊断为不明来源的脑栓塞:NAVIGATE ESUS 的亚分析。
Int J Stroke. 2019 Dec;14(9):915-922. doi: 10.1177/1747493019852177. Epub 2019 May 27.
5
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.日本高危缺血性脑卒中患者使用西洛他唑进行二级预防的双联抗血小板治疗:一项多中心、开放标签、随机对照试验。
Lancet Neurol. 2019 Jun;18(6):539-548. doi: 10.1016/S1474-4422(19)30148-6.
6
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.达比加群酯预防来源不明的栓塞性卒中后卒中
N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959.
7
Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I).普拉格雷与氯吡格雷在非心源性缺血性脑卒中患者中的比较:一项 3 期、随机、非劣效性试验(PRASTRO-I)。
Lancet Neurol. 2019 Mar;18(3):238-247. doi: 10.1016/S1474-4422(18)30449-6. Epub 2019 Feb 12.
8
Rivaroxaban administration after acute ischemic stroke: The RELAXED study.利伐沙班用于急性缺血性脑卒中后的治疗:RELAXED 研究。
PLoS One. 2019 Feb 13;14(2):e0212354. doi: 10.1371/journal.pone.0212354. eCollection 2019.
9
Primary and secondary prevention of stroke and systemic embolism with rivaroxaban in patients with non-valvular atrial fibrillation : Sub-analysis of the EXPAND Study.利伐沙班用于非瓣膜性心房颤动患者卒中及全身性栓塞的一级和二级预防:EXPAND研究的亚组分析
Heart Vessels. 2019 Jan;34(1):141-150. doi: 10.1007/s00380-018-1219-0. Epub 2018 Jul 6.
10
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.氯吡格雷和阿司匹林在急性缺血性卒中和高风险 TIA 中的应用。
N Engl J Med. 2018 Jul 19;379(3):215-225. doi: 10.1056/NEJMoa1800410. Epub 2018 May 16.